| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.099 | 0.04 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.32 | 0.04 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.05 |